[Prematurity and dysmaturity prevention program (PDP program)].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D001724:Birth Weight; D001925:Brain Damage, Chronic / Q000209:etiology; D002675:Child, Preschool; D005260:Female; D005313:Fetal Death / Q000517:prevention & control; D005315:Fetal Diseases / Q000517:prevention & control; D005865:Gestational Age; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D007234:Infant, Premature; D009748:Nutrition Disorders / Q000517:prevention & control; D007752:Obstetric Labor, Premature / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D011247:Pregnancy; D002577:Uterine Cervical Diseases / Q000150:complications / Q000601:surgery
D000318:Adrenergic beta-Agonists
Prämaturitäts- und Dysmaturitäts-Präventionsprogramm (PDP-Programm.